Navigation Links
PAREXEL Reports Third Quarter Fiscal Year 2009 Financial Results
Date:4/27/2009

619 $20,280 % of total service revenue 13.5% 8.3% Gross profit $15,540 $7,738 Gross margin % of service revenue 43.6% 38.2% Total service revenue $264,457 $245,336 Total gross profit $98,676 $84,073 Gross margin % of service revenue 37.3% 34.3% Revenue by Geography -------------------- The Americas $113,551 $99,735 Europe, Middle East & Africa 126,666 129,105 Asia/Pacific 24,240 16,496 ------ ------ Total service revenue $264,457 $245,336 ======== ======== Quarterly Supplemental Financial Data ------------------------------------- Total revenue $310,961 $294,723 Investigator fees 44,781 38,496 ------ ------ Gross revenue $355,742 $333,219 ======== ======== Days Sales Outstanding 47 59 Capital expenditures $16,651 $18,794 PAREXEL International Corporation Segment Information ($ in thousands) Unaudited Nine Months Ended ----------------- March 31, 2009 March 31, 2008 -------------- -------------- As As
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. PAREXEL Receives BioSingapore Award for Best Performing CRO
2. PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting
3. PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009
4. PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting
5. PAREXEL Appoints Josephine Hoppe to Chief Information Officer
6. PAREXEL International to Present at the 27th Annual JP Morgan Healthcare Conference
7. PAREXEL Receives Best CRO Award from Scrip
8. PAREXEL Establishes Alliance with SITS Network of Clinical Sites Specializing in Stroke Studies
9. PAREXEL Expands Pioneering Asian Ethnobridging Expertise
10. PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress
11. PAREXEL International to Present at Oppenheimer 19th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014   MSC , a ... safety, today announced the appointment of Mary Beth ... With 28 years of experience preparing companies for rapid ... as Executive Vice President of Corporate Development and Healthcare. ... improvement business , as well as corporate strategy and ...
(Date:8/27/2014)... 27, 2014 The Global and China ... on the current state of the Trifluoroacetic Acid industry ... basic overview of the industry, including definitions, applications and ... market analysis are provided with a focus on history, ... comparison between the international and Chinese situation is also ...
(Date:8/27/2014)... Aug. 27, 2014 Research and ... "Global Lactic Acid  (Biodegradable Polymer, Food & Beverage, ... Forecasts to 2019" report to their offering. ... acid with an asymmetrical carbon atom. The main ... polymer, food and beverage, personal care product, and ...
(Date:8/27/2014)... , Aug. 27, 2014  A novel biomarker ... help physicians better identify early-stage disease, when treatment ... according to a new study in The Journal ... (NYSE: DGX ) and other institutions ... protein outperformed conventional antibody-serum testing, including rheumatoid factor ...
Breaking Biology Technology:MSC names Mary Beth Loesch President and CEO 2Trifluoroacetic Acid Industry (Asia, Europe, North America, ROW) Analysis Report Now Available at ReportsnReports.com 2Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 3Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 4
... TRIANGLE PARK, N.C., Aug. 27 NovaQuest ... Inc., a,clinical-stage biopharmaceutical company specializing in respiratory,disorders. ... placement of C$26 million,(US$25 million) in the ... by NovaQuest, the strategic partnering group,of Quintiles ...
... HONG KONG, Aug. 27 /Xinhua-PRNewswire-FirstCall/ -- China Technology,Development ... today,announced the appointment of Charlene Hua as the ... pursuant to a board,resolution passed on the same ... Committee of the Company. As Chief Financial ...
... BRIDGEWATER, N.J., Aug. 27 Sanofi-aventis,U.S. launched today ... chemotherapy,treatment Eloxatin(R) (oxaliplatin injection) for patients who have,adjuvant ... which is,expected to offer more convenience, efficiency and ... Previously, Eloxatin(R) had been,available in 50 mg and ...
Cached Biology Technology:NovaQuest Advances 'Virtual Development' Model With Strategic Investment in TOPIGEN Pharmaceuticals 2China Technology Announces New Chief Financial Officer 2China Technology Announces New Chief Financial Officer 3New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 2New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 3New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 4New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 5New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 6New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation 7
(Date:8/28/2014)... FASEB MARC (Maximizing Access to Research Careers) ... the American College of Sports Medicine,s Conference on ... in Miami, Florida. These awards are meant ... and scientists from underrepresented groups into the mainstream ... the participation of young scientists at the American ...
(Date:8/28/2014)... new roads will be built worldwide by 2050. Many ... where they bring an influx of destructive loggers, hunters ... has created a ,global roadmap, for prioritising road building ... demands of development and environmental protection. , The map ... natural importance of ecosystems and a ,road-benefits, layer that ...
(Date:8/28/2014)... exports from Washington, Oregon, northern California, and Alaska totaled ... quarter of 2014, an increase of more than 10 ... U.S. Forest Service,s Pacific Northwest Research Station reported today. ... by 4 percent to 247 million board feet. , ... more than 5 percent to $390 million in the ...
Breaking Biology News(10 mins):Study shows where on the planet new roads should and should not go 2Study shows where on the planet new roads should and should not go 3West coast log exports up, lumber exports down in second quarter of 2014 2
... This release is available in German . ... that Nadja Knoll found new proof in the nomad people of ... nutritionist from the Friedrich Schiller University Jena (Germany) analyzed the diet ... of the field study show that the Maasai are in a ...
... PROVIDENCE, R.I. [Brown University] In 1988, a mysterious invader ... likely arrived in ballast from commercial ships, and it found ... decades later, the crab, Hemigrapsus sanguineus , has expanded ... southward to North Carolina. Its numbers continue to expand, and ...
... ORLEANS, LA Broncus Technologies, Inc., a medical device ... diseases, announced today at the American Thoracic Society ... system version 2.1. The bronchoscopic navigation system is ... These highlight the clinical benefits of using the ...
Cached Biology News:Nomad people baffle with good health in spite of malnourishment 2Are invasives bad? Not always, say Brown researchers 2LungPoint system results presented at American Thoracic Society 2010 International Conference 2LungPoint system results presented at American Thoracic Society 2010 International Conference 3
... an automated hybridization system for the processing ... the hybridization and post hybridization washing of ... instrument can process up to 12 slides ... multi-protocol software, enabling the user to run ...
a1-Antitrypsin (human, alpha-1 AT)...
C1-inhibitor (C1-INH)...
Glucagon-like peptide-1 (GLP-1 (1-36) amide)...
Biology Products: